Sahil Kirpekar
Corporate Officer/Principal bei ATAI LIFE SCIENCES N.V.
Vermögen: 100 792 $ am 31.05.2024
Profil
Sahil Kirpekar is currently the Head-Business Development at Otsuka Pharmaceutical Co., Ltd.
and the Chief Business Officer at ATAI Life Sciences NV.
Previously, he worked as a Director at IntelGenx Technologies Corp.
Dr. Kirpekar is a graduate of the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATAI LIFE SCIENCES N.V.
0,04% | 02.04.2024 | 64 199 ( 0,04% ) | 100 792 $ | 31.05.2024 |
Aktive Positionen von Sahil Kirpekar
| Unternehmen | Position | Beginn |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Corporate Officer/Principal | 29.11.2022 |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 01.01.2022 |
Ehemalige bekannte Positionen von Sahil Kirpekar
| Unternehmen | Position | Ende |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Direktor/Vorstandsmitglied | 17.05.2024 |
Ausbildung von Sahil Kirpekar
| University of Cambridge | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Health Technology |
